Session takeaways:
- Reprogramming Discovery
- The HYFT® Breakthrough
- The Frontier of Explainable AI in Biology
Dirk Van Hyfte MD, PhD
Dirk Van Hyfte stands at the forefront of innovation where artificial intelligence and biology intersect. As Chief Technology Officer of MindWalk, a Bio-Native AI company, Dirk leads transformative research powered by patented HYFT® technology and the LensAI™ platform—cutting-edge tools that unify biological data for accelerated drug discovery and development.
With a degree in Medicine and specialization as a Psychiatrist from the prestigious University of Leuven in Belgium and a PhD in medical artificial intelligence from Nijmegen University, Dirk combines deep clinical knowledge with pioneering expertise in computational science. Dirk’s expertise extends beyond the realms of technology and business. His entrepreneurial vision is reflected in the creation of iKnow, a natural language processing platform acquired by InterSystems, a global data technology leader, in 2010.
Dirk’s leadership has positioned MindWalk as a driving force in explainable and scalable biological AI, moving the field toward an era where biology itself computes, learns, and reveals new therapeutic frontiers.
At AIDDD 25, Dirk Van Hyfte and Holly Soutter will share insights on reprogramming the entire drug discovery process, presenting the HYFT® breakthrough that enables biology to "compute itself"—making complex biological connections explainable, accessible, and actionable for the first time. This session will explore:
- Reprogramming Discovery: How AI-native platforms are reshaping how scientists interact with biological data and design new therapies.
- The HYFT® Breakthrough: Unveiling a novel computational approach that decodes universal biosphere patterns, unlocking unprecedented discovery potential.
- The Frontier of Explainable AI in Biology: Transcending black-box models to deliver clarity, transparency, and trust in AI-powered biological research.
